Yıl: 2021 Cilt: 4 Sayı: 4 Sayfa Aralığı: 314 - 321 Metin Dili: İngilizce DOI: 10.30714/j-ebr.2021471926 İndeks Tarihi: 10-02-2022

The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection

Öz:
Aim: COVID-19 infections the tissue through angiotensin converting enzyme 2 receptor, which is alsoexpressed on endothelial cells. Endothelial dysfunction may be associated with lung involvement. Asymmetricdimethylarginine (ADMA) is an indirect marker of endothelial dysfunction. The aim of our study was toevaluate ADMA concentrations and to identify its association with lung involvement in patients with COVID 19 disease. Methods: We included 42 patients with COVID-19 infection and lung involvement (Group 1). Forty-two ageand sex matched patients without pneumonia acted as the control group (Group 2). All patients gave bloodsamples for ADMA at the 1st month control visit after discharge. We compared C-reactive protein (CRP) andADMA concentrations in addition to routine biochemical parameters between groups. Results: Patients with lung involvement had higher admission glucose, CRP, and ADMA concentrations, anddisplayed lower hemoglobin concentration and lymphocyte count compared to patients without lunginvolvement. Although patients with lung involvement had higher ADMA concentrations with respect to thosewithout; plasma ADMA levels were also higher than normal values in control group. Multivariate analysisidentified log CRP concentration (OR= 3.047, 95% CI=1.881-5.023, p<0.001) as the independent predictorfor lung involvement. And, there was a correlation between ADMA and CRP (r: 0.318, p: 0.003). Conclusion: We revealed elevated ADMA concentrations as the surrogate of endothelial dysfunction inCOVID-19 patients whether they have pneumonia or not.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • [1]Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr. 2020;63(4):119-24.
  • [2]World Health organization; WCDCCoronavirus Disease (COVID-19) Dashboard [updated 05/09/2020.
  • [3]Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;(323):1239- 42.
  • [4]Ferrario CM, Jessup J, Chappell MC, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;(111):2605-10.
  • [5]Flammer AJ, Anderson T, Celermajer DS, et al. The assessment of endothelial function: from research into clinical practice. Circulation. 2012;(126):753-67.
  • [6]Cekmen M, Turgut M, Turkoz Y, et al. Nitric Oxide and Nitric Oxide Synthaze Physiologic and Pathologic Characterictics. T Klin J Ped. 2001;(10):226-35.
  • [7]Raghavan SA, Dikshit M. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacol Res. 2004;(49):397-14.
  • [8]Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;(395):1417- 18.
  • [9]Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168-75.
  • [10]Ciceri F, Beretta L, Scandroglio AM, et al Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020;22(2):95-97.
  • [11]Cooke JP. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation. 1997;(96):379-82.
  • [12]Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide. 2001;(5):88- 97.
  • [13]Nijveldt RJ, Teerlink T, Van Der Hoven B, Siroen MP, Kuik DJ, Rauwerda JA, van Leeuwen PA. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr. 2003;22(1):23-30.
  • [14]Nijveldt RJ, Teerlink T, van Leeuwen PA. The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr. 2003;22(1):99-104.
  • [15]Burgner DP, Sabin MA, Magnussen CG, et al. Early childhood hospitalisation with infection and subclinical atherosclerosis in adulthood: the Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2015;(239):496-502.
  • [16]Ling W. C-reactive protein levels in the early stage of COVID-19. Medecine et Maladies Infectieuses. 2020;50(4):332-34.
  • [17]Herold T, Jurinovic V, Arnreich C, et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID19. J Allergy Clin Immunol. 2020;146(1):128-136.e4.
  • [18]Singh U, Devaraj S, Vasquez-Vivar J, et al. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol. 2007;(43):780-91.
  • [19]Triches CB, Mayer S, Quinto BMR, et al. Association of endothelial dysfunction with cardiovascular risk factors and new‐onset diabetes mellitus in patients with hypertension. J Clin Hypertens. 2018;(20):935-41.
  • [20]Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000;20(9):2032-37.
  • [21]Baylis C. Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol. 2006;2(4):209-20.
APA emlek n, Yilmaz A, Ergül E, GÜNDOĞDU H, ARPA M, KOÇ H, ÖZTÜRK M, AYDIN C (2021). The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection. , 314 - 321. 10.30714/j-ebr.2021471926
Chicago emlek nadir,Yilmaz Ahmet Seyda,Ergül Elif,GÜNDOĞDU Hasan,ARPA Medeni,KOÇ Haldun,ÖZTÜRK Muhammet,AYDIN Cihan The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection. (2021): 314 - 321. 10.30714/j-ebr.2021471926
MLA emlek nadir,Yilmaz Ahmet Seyda,Ergül Elif,GÜNDOĞDU Hasan,ARPA Medeni,KOÇ Haldun,ÖZTÜRK Muhammet,AYDIN Cihan The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection. , 2021, ss.314 - 321. 10.30714/j-ebr.2021471926
AMA emlek n,Yilmaz A,Ergül E,GÜNDOĞDU H,ARPA M,KOÇ H,ÖZTÜRK M,AYDIN C The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection. . 2021; 314 - 321. 10.30714/j-ebr.2021471926
Vancouver emlek n,Yilmaz A,Ergül E,GÜNDOĞDU H,ARPA M,KOÇ H,ÖZTÜRK M,AYDIN C The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection. . 2021; 314 - 321. 10.30714/j-ebr.2021471926
IEEE emlek n,Yilmaz A,Ergül E,GÜNDOĞDU H,ARPA M,KOÇ H,ÖZTÜRK M,AYDIN C "The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection." , ss.314 - 321, 2021. 10.30714/j-ebr.2021471926
ISNAD emlek, nadir vd. "The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection". (2021), 314-321. https://doi.org/10.30714/j-ebr.2021471926
APA emlek n, Yilmaz A, Ergül E, GÜNDOĞDU H, ARPA M, KOÇ H, ÖZTÜRK M, AYDIN C (2021). The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection. Experimental Biomedical Research, 4(4), 314 - 321. 10.30714/j-ebr.2021471926
Chicago emlek nadir,Yilmaz Ahmet Seyda,Ergül Elif,GÜNDOĞDU Hasan,ARPA Medeni,KOÇ Haldun,ÖZTÜRK Muhammet,AYDIN Cihan The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection. Experimental Biomedical Research 4, no.4 (2021): 314 - 321. 10.30714/j-ebr.2021471926
MLA emlek nadir,Yilmaz Ahmet Seyda,Ergül Elif,GÜNDOĞDU Hasan,ARPA Medeni,KOÇ Haldun,ÖZTÜRK Muhammet,AYDIN Cihan The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection. Experimental Biomedical Research, vol.4, no.4, 2021, ss.314 - 321. 10.30714/j-ebr.2021471926
AMA emlek n,Yilmaz A,Ergül E,GÜNDOĞDU H,ARPA M,KOÇ H,ÖZTÜRK M,AYDIN C The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection. Experimental Biomedical Research. 2021; 4(4): 314 - 321. 10.30714/j-ebr.2021471926
Vancouver emlek n,Yilmaz A,Ergül E,GÜNDOĞDU H,ARPA M,KOÇ H,ÖZTÜRK M,AYDIN C The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection. Experimental Biomedical Research. 2021; 4(4): 314 - 321. 10.30714/j-ebr.2021471926
IEEE emlek n,Yilmaz A,Ergül E,GÜNDOĞDU H,ARPA M,KOÇ H,ÖZTÜRK M,AYDIN C "The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection." Experimental Biomedical Research, 4, ss.314 - 321, 2021. 10.30714/j-ebr.2021471926
ISNAD emlek, nadir vd. "The relationship of serum asymmetric dimethylarginine concentrations and lunginvolvement in patients with COVID-19 infection". Experimental Biomedical Research 4/4 (2021), 314-321. https://doi.org/10.30714/j-ebr.2021471926